Legal Representation
Attorney
Cynthia A. Moyer
Application History
36 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 21, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Jun 20, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Nov 16, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 20, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Oct 20, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Oct 20, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Oct 20, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Oct 20, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sep 21, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 21, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 1, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 19, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Aug 19, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Aug 19, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Aug 19, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Aug 19, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 19, 2021 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Aug 19, 2021 | HSCD | I | HIDDEN SENSITIVE CONTENT |
| Aug 19, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Aug 19, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Aug 19, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Aug 19, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Aug 19, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 12, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 11, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Aug 11, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 11, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 11, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 11, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 11, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 11, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 11, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 11, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 11, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 1, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 10, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 044
medical treatment, namely, administering gene therapies in the nature of in vivo and ex vivo vector treatments; medical treatment, namely, administering gene therapies in the nature of lentiviral vector therapies; medical treatment, namely, administering gene therapies in the nature of gene therapies for the treatment of rare diseases; medical treatment, namely, administering gene therapies in the nature of gene therapies for Hereditary Tyrosinemia Type 1; medical treatment, namely, administering gene therapies in the nature of gene therapies for orphan disease; medical treatment, namely, administering gene therapies in the nature of gene therapies for inborn errors of hepatic metabolism
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The words "novavita thera" has no meaning in a foreign language.
Classification
International Classes
044